Baidu
map

感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2018 比利时指南：HIV感染患者潜伏性结核筛查

2018-07-23 国外感染病相关专家组（统称） Acta Clin Belg. 2018 Jul 23:1-10.

HIV感染潜伏性结核

结核杆菌是结核病的主要致病原因，本文主要回顾了HIV感染成人筛查潜伏性结核感染的最新知识，并提供了实践指导。主要建议内容涉及筛选人群，检测方法，筛查时机以及潜伏性结核感染的治疗。

中文标题：

2018 比利时指南：HIV感染患者潜伏性结核筛查

英文标题：

2018 Belgian guidelines for the screening for latent tuberculosis in HIV-infected patients.

发布机构：

国外感染病相关专家组（统称）

发布日期：

2018-07-23

简要介绍：

结核杆菌是结核病的主要致病原因，本文主要回顾了HIV感染成人筛查潜伏性结核感染的最新知识，并提供了实践指导。主要建议内容涉及筛选人群，检测方法，筛查时机以及潜伏性结核感染的治疗。 

拓展指南：与结核相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 比利时指南：HIV感染患者潜伏性结核筛查)] GetToolGuiderByIdResponse(projectId=1, id=993081c001620117, title=2018 比利时指南：HIV感染患者潜伏性结核筛查, enTitle=2018 Belgian guidelines for the screening for latent tuberculosis in HIV-infected patients., guiderFrom=Acta Clin Belg. 2018 Jul 23:1-10., authorId=null, author=, summary=结核杆菌是结核病的主要致病原因，本文主要回顾了HIV感染成人筛查潜伏性结核感染的最新知识，并提供了实践指导。主要建议内容涉及筛选人群，检测方法，筛查时机以及潜伏性结核感染的治疗。 , cover=, journalId=null, articlesId=null, associationId=1273, associationName=国外感染病相关专家组（统称）, associationIntro=, copyright=0, guiderPublishedTime=Mon Jul 23 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>结核杆菌是结核病的主要致病原因，本文主要回顾了HIV感染成人筛查潜伏性结核感染的最新知识，并提供了实践指导。主要建议内容涉及筛选人群，检测方法，筛查时机以及潜伏性结核感染的治疗。 </div> <div><br> </div> 拓展指南：<strong>与<font color=red>结核</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=bc0a91c001611961" title="肺结核影像学及分级诊断专家共识" target=_blank>肺结核影像学及分级诊断专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=85e721c00160a8c4" title="抗结核药物超说明书用法专家共识" target=_blank>抗结核药物超说明书用法专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=70c221c0015980d4" title="2018 WHO指南： 异烟肼耐药结核病的治疗" target=_blank>2018 WHO指南： 异烟肼耐药结核病的治疗</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=e4a881c0015ae218" title="利奈唑胺抗结核治疗专家共识" target=_blank>利奈唑胺抗结核治疗专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=f3ca41c0015a6682" title="结核病重症加强治疗病房建设与管理专家共识（2018）" target=_blank>结核病重症加强治疗病房建设与管理专家共识（2018）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E7%BB%93%E6%A0%B8" target=_blank>有关结核更多指南</a></ul>, tagList=[TagDto(tagId=3709, tagName=HIV感染), TagDto(tagId=78379, tagName=潜伏性结核)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4863, appHits=104, showAppHits=0, pcHits=3163, showPcHits=2083, likes=126, shares=3, comments=8, approvalStatus=1, publishedTime=Thu Jul 26 22:55:54 CST 2018, publishedTimeString=2018-07-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 26 22:55:54 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 12:59:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 比利时指南：HIV感染患者潜伏性结核筛查)])
2018 比利时指南：HIV感染患者潜伏性结核筛查
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=345643, encodeId=997934564356, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Sep 19 09:00:08 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343739, encodeId=3c89343e39a1, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Sep 08 16:33:59 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342488, encodeId=78be342488e6, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Sep 03 18:49:38 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338501, encodeId=b05f33850127, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Aug 14 09:12:22 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335800, encodeId=959f3358006d, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Aug 02 15:06:17 CST 2018, time=2018-08-02, status=1, ipAttribution=)]
    2018-09-19 大爰

    学习了谢谢分享！！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=345643, encodeId=997934564356, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Sep 19 09:00:08 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343739, encodeId=3c89343e39a1, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Sep 08 16:33:59 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342488, encodeId=78be342488e6, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Sep 03 18:49:38 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338501, encodeId=b05f33850127, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Aug 14 09:12:22 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335800, encodeId=959f3358006d, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Aug 02 15:06:17 CST 2018, time=2018-08-02, status=1, ipAttribution=)]
    2018-09-08 大爰

    学习并分享！！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=345643, encodeId=997934564356, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Sep 19 09:00:08 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343739, encodeId=3c89343e39a1, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Sep 08 16:33:59 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342488, encodeId=78be342488e6, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Sep 03 18:49:38 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338501, encodeId=b05f33850127, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Aug 14 09:12:22 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335800, encodeId=959f3358006d, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Aug 02 15:06:17 CST 2018, time=2018-08-02, status=1, ipAttribution=)]
    2018-09-03 大爰

    学习了谢谢分享！！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=345643, encodeId=997934564356, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Sep 19 09:00:08 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343739, encodeId=3c89343e39a1, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Sep 08 16:33:59 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342488, encodeId=78be342488e6, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Sep 03 18:49:38 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338501, encodeId=b05f33850127, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Aug 14 09:12:22 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335800, encodeId=959f3358006d, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Aug 02 15:06:17 CST 2018, time=2018-08-02, status=1, ipAttribution=)]
    2018-08-14 大爰

    学习了谢谢分享！！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=345643, encodeId=997934564356, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Sep 19 09:00:08 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343739, encodeId=3c89343e39a1, content=学习并分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Sep 08 16:33:59 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342488, encodeId=78be342488e6, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Sep 03 18:49:38 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338501, encodeId=b05f33850127, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Aug 14 09:12:22 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=335800, encodeId=959f3358006d, content=学习了谢谢分享！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Aug 02 15:06:17 CST 2018, time=2018-08-02, status=1, ipAttribution=)]
    2018-08-02 大爰

    学习了谢谢分享！！

    0

相关指南

2018 HHS指南：HIV感染的成人及青少年应用抗逆转录病毒药物治疗

美国卫生和公共服务部(HHS,U.S. Department of Health and Human Services) · 2018-03-27

2017 加拿大HIV暴露前预防和非职业性暴露后预防指南

国外感染病相关专家组（统称） · 2017-11-27

2017 IDSA临床实践指南：HIV感染患者慢性疼痛的管理

美国感染病学会(IDSA,Infectious Diseases Society of America) · 2017-09-14

HIV感染合并慢性肾脏病患者管理专家共识

中国感染病相关专家组（统称） · 2017-06-15

2016 ACOG实践简报：HIV感染青少年和女性的妇科照护（No.167）

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2016-10-15

Baidu
map
Baidu
map
Baidu
map